Table 1.
Clinicopathological features and correlation of TET2 expression in HCC.
Case number | TET2 expression | |||
---|---|---|---|---|
Characteristics | N = 78 | Low (58) | High (20) | P-value |
Gender | 0.536 | |||
Male | 61 | 44 | 17 | |
Female | 17 | 14 | 3 | |
Age | 0.303 | |||
≤55 | 38 | 26 | 12 | |
>55 | 40 | 32 | 8 | |
Tumor diameter (cm) | 0.036 | |||
≤5.0 | 41 | 26 | 15 | |
>5.0 | 37 | 32 | 5 | |
TNM stage | 0.207 | |||
I + II | 37 | 25 | 12 | |
III + IV | 41 | 33 | 8 | |
Distant metastasis | 1.000 | |||
No | 65 | 48 | 17 | |
Yes | 13 | 10 | 3 | |
Pathological stage | 0.499 | |||
I + II | 64 | 46 | 18 | |
III + IV | 14 | 12 | 2 | |
Relapse | 0.441 | |||
No | 40 | 28 | 12 | |
Yes | 38 | 30 | 8 |